tradingkey.logo

NewGenIvf Group Ltd

NIVF
查看詳細走勢圖
1.000USD
0.0000.00%
收盤 02/06, 16:00美東報價延遲15分鐘
143.51K總市值
0.00本益比TTM

NewGenIvf Group Ltd

1.000
0.0000.00%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

-27.01%

1月

-46.24%

6月

-89.19%

今年開始到現在

-51.69%

1年

-99.85%

查看詳細走勢圖

TradingKey NewGenIvf Group Ltd股票評分

單位: USD 更新時間: 2026-02-06

操作建議

NewGenIvf Group Ltd當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力較大。當前估值低估,在醫療服務供應商行業排名69/75位。機構持股佔比低,近一月多位分析師給出公司評級為。最高目標價為225.00。中期看,股價處於下降通道。

NewGenIvf Group Ltd評分

相關信息

行業排名
69 / 75
全市場排名
541 / 4521
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

NewGenIvf Group Ltd亮點

亮點風險
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
業績增長期
公司處於發展階段,最新年度總收入5.43M美元
業績轉虧
公司業績轉虧,最新年度虧損美元
估值合理
公司最新PE估值0.00,處於3年歷史合理位
機構加倉
最新機構持股1.53K股,環比增加43.38%

分析師目標

基於 0 分析師
--
評級
225.000
目標均價
+25152.53%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

NewGenIvf Group Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

NewGenIvf Group Ltd簡介

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
公司代碼NIVF
公司NewGenIvf Group Ltd
CEOWing Fung (Siu)
網址https://newgenivf.com/
KeyAI